PERINDOPRIL/AMLODIPINE-GX 10/5 perindopril arginine 10 mg/amlodipine 5 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

perindopril/amlodipine-gx 10/5 perindopril arginine 10 mg/amlodipine 5 mg tablet bottle

medis pharma pty ltd - amlodipine besilate, quantity: 6.94 mg; perindopril arginine, quantity: 10 mg - tablet - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate; crospovidone; magnesium stearate; trehalose dihydrate; light magnesium oxide; glycerol dibehenate; sodium starch glycollate - perindopril/amlodipine is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

PERINDOPRIL/AMLODIPINE-MEDIS 5/5 perindopril arginine 5 mg/amlodipine 5 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

perindopril/amlodipine-medis 5/5 perindopril arginine 5 mg/amlodipine 5 mg tablet bottle

medis pharma pty ltd - amlodipine besilate, quantity: 6.94 mg; perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: crospovidone; trehalose dihydrate; light magnesium oxide; calcium hydrogen phosphate; sodium starch glycollate; magnesium stearate; microcrystalline cellulose; glycerol dibehenate - perindopril/amlodipine is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

PERINDOPRIL/AMLODIPINE-GX 5/5 perindopril arginine 5 mg/amlodipine 5 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

perindopril/amlodipine-gx 5/5 perindopril arginine 5 mg/amlodipine 5 mg tablet bottle

medis pharma pty ltd - amlodipine besilate, quantity: 6.94 mg; perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: microcrystalline cellulose; light magnesium oxide; trehalose dihydrate; calcium hydrogen phosphate; glycerol dibehenate; crospovidone; sodium starch glycollate; magnesium stearate - perindopril/amlodipine is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

PERINDOPRIL/AMLODIPINE-AS 10/10 perindopril arginine 10 mg/amlodipine 10 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

perindopril/amlodipine-as 10/10 perindopril arginine 10 mg/amlodipine 10 mg tablet bottle

medis pharma pty ltd - amlodipine besilate, quantity: 13.88 mg; perindopril arginine, quantity: 10 mg - tablet - excipient ingredients: crospovidone; microcrystalline cellulose; trehalose dihydrate; glycerol dibehenate; calcium hydrogen phosphate; light magnesium oxide; magnesium stearate; sodium starch glycollate - perindopril/amlodipine is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

Perindopril Arginine/Amlodipine 5/5 APOTEX perindopril arginine 5 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

perindopril arginine/amlodipine 5/5 apotex perindopril arginine 5 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

Perindopril Arginine/Amlodipine 10/5 APOTEX perindopril arginine 10 mg and amlodipine (as besilate) 5 mg uncoated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

perindopril arginine/amlodipine 10/5 apotex perindopril arginine 10 mg and amlodipine (as besilate) 5 mg uncoated tablet blister pack

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); perindopril arginine, quantity: 10 mg - tablet - excipient ingredients: magnesium stearate; colloidal anhydrous silica; croscarmellose sodium; microcrystalline cellulose - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

Perindopril Arginine/Amlodipine 10/10 APOTEX perindopril arginine 10 mg and amlodipine (as besilate) 10 mg uncoated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

perindopril arginine/amlodipine 10/10 apotex perindopril arginine 10 mg and amlodipine (as besilate) 10 mg uncoated tablet blister pack

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); perindopril arginine, quantity: 10 mg - tablet - excipient ingredients: croscarmellose sodium; magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

Perindopril Arginine/Amlodipine 5/10 APOTEX perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

perindopril arginine/amlodipine 5/10 apotex perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet blister pack

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

Perindopril Arginine/Amlodipine 10/5 APOTEX perindopril arginine 10 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

perindopril arginine/amlodipine 10/5 apotex perindopril arginine 10 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); perindopril arginine, quantity: 10 mg - tablet - excipient ingredients: croscarmellose sodium; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.